|
Prescription Drug Search
Product Request Form
Istodax is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Istodax becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Istodax:
- Anguilla
- Armenia
- Aruba
- Bahamas
- Barbados
- Bermuda
- Bolivia
- Bosnia and Herzegovina
- Chile
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- El Salvador
- Georgia
- Greenland
- Guatemala
- Honduras
- Hong Kong
- India
- Ireland
- Jamaica
- Kuwait
- Lithuania
- Luxembourg
- Mauritius
- Netherlands
- New Zealand
- Panama
- Paraguay
- Portugal
- Romania
- Seychelles
- Slovakia
- Spain
- Switzerland
- Trinidad and Tobago
- United Kingdom, UK
- United States, US
- Uruguay
Latest news releases on Istodax:
Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report - new company profile report - Transworld News
The company has three marketed products, REVLIMID, THALOMID and VIDAZA, ABRAXANE, and ISTODAX. The company's operations are spread across more than 65 countries and regions, including Europe, Latin America, Middle East, Asia-Pacific and Canada. It operates ...
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 - Xconomy
There are also more targeted drugs like Eisai Pharmaceuticals’ bexarotene (Targretin), Merck’s vorinostat (Zolinza), or Celgene’s romidepsin (Istodax). But once patients progress past the early rounds of therapy, no treatments have shown ...
Celgene Retains Neutral Rec - Zacks.com
Apart from Revlimid, the oncology portfolio at Celgene also includes Vidaza, Abraxane, Istodax and Thalomid. Moreover, the company is investing heavily in its pipeline with multiple pipeline events lined up in the coming quarters. The most eagerly awaited ...
8 Biotechnology Stocks With Good Liquidity That Analysts Rate As Buy - Seekingalpha.com
It also offers ABRAXANE to treat metastatic breast cancer; and ISTODAX for the treatment of cutaneous and peripheral T-cell lymphoma. Dyax Corp. has a Current Ratio of 3.06 and Quick Ratio of 2.71 and Analysts' Rating of 2.30. The short interest was 4.45% ...
Celgene Retains Neutral Rec - Analyst Blog - Boston Globe
Apart from Revlimid, the oncology portfolio at Celgene also includes Vidaza, Abraxane, Istodax and Thalomid. Moreover, the company is investing heavily in its pipeline with multiple pipeline events lined up in the coming quarters. The most ...
